Literature DB >> 32771503

Application of polyvinyl acetate in an innovative formulation strategy for lyophilized orally disintegrating tablets.

Brecht Vanbillemont1, Thomas De Beer2.   

Abstract

Orally disintegrating tablets (ODTs) manufactured by freeze-drying, also called oral lyophilizates, are a patient-centred dosage form. They possess ultra-fast disintegration dynamics, have acceptable mechanical strength and have a smooth mouth texture. In this study, polyvinyl alcohol (PVA) was investigated as an alternative polymeric binder to gelatin for ODT formulations. A low- and high-dose formulation were in-scope with mannitol as filler and xanthan gum as a viscosity enhancer. Design of experiments (DoE) methodology was applied to study the formulation effects on several quality attributes. Sedimentation during the initial phases of freeze-drying was successfully measured using Raman spectroscopy and could be minimized by adjusting the xanthan gum concentration. Multiple linear regression models were subsequently applied to establish design spaces and robust optimised formulations. A 19 mg hydrochlorothiazide (HCT) as low-dose and 500 mg paracetamol as high-dose ODT were developed in this study. The work displayed the use of PVA as a viable polymeric binder, and alternative for gelatin, in lyophilized ODTs.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cold-form blisters; Design space; Formulation optimization; Orodispersable tablets; Surface modeling

Mesh:

Substances:

Year:  2020        PMID: 32771503     DOI: 10.1016/j.ijpharm.2020.119717

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   6.510


  3 in total

Review 1.  Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.

Authors:  Mohammadali Poursharifi Ghourichay; Seyed Hossein Kiaie; Ali Nokhodchi; Yousef Javadzadeh
Journal:  Biomed Res Int       Date:  2021-12-24       Impact factor: 3.411

2.  Milk Oral Lyophilizates with Loratadine: Screening for New Excipients for Pediatric Use.

Authors:  Sonia Iurian; Cătălina Bogdan; Ștefana Suciu; Dana-Maria Muntean; Lucia Rus; Mihaela Berindeie; Szidonia Bodi; Rita Ambrus; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-06-24       Impact factor: 6.525

Review 3.  Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.

Authors:  Andreea Cornilă; Sonia Iurian; Ioan Tomuță; Alina Porfire
Journal:  Pharmaceutics       Date:  2022-08-03       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.